Details for New Drug Application (NDA): 204640
✉ Email this page to a colleague
The generic ingredient in ADRENALIN is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
Summary for 204640
Tradename: | ADRENALIN |
Applicant: | Endo Operations |
Ingredient: | epinephrine |
Patents: | 3 |
Pharmacology for NDA: 204640
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Medical Subject Heading (MeSH) Categories for 204640
Suppliers and Packaging for NDA: 204640
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ADRENALIN | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 204640 | NDA | Endo USA, Inc. | 42023-168 | 42023-168-99 | 1 VIAL in 1 CARTON (42023-168-99) / 30 mL in 1 VIAL |
ADRENALIN | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 204640 | NDA | Endo USA, Inc. | 42023-168 | 42023-168-01 | 1 VIAL in 1 CARTON (42023-168-01) / 30 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | Strength | EQ 30MG BASE/30ML (EQ 1MG BASE/ML) | ||||
Approval Date: | Dec 18, 2013 | TE: | AP | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 13, 2035 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 13, 2035 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 13, 2035 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS |
Complete Access Available with Subscription